Stuart Sprague to Peptides
This is a "connection" page, showing publications Stuart Sprague has written about Peptides.
Connection Strength
0.383
-
Incorporation of Calcimimetics into End-Stage Kidney Disease Bundle: Changes in Etelcalcetide Utilization and Parathyroid Hormone Control following End of Transitional Drug Add-On Payment Adjustment Designation. Clin J Am Soc Nephrol. 2025 Feb 01; 20(2):218-228.
Score: 0.166
-
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial. Adv Ther. 2024 06; 41(6):2500-2518.
Score: 0.161
-
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial. J Bone Miner Res. 2026 Aug 21; 41(9):922-933.
Score: 0.047
-
A novel nervous system beta subunit that downregulates human large conductance calcium-dependent potassium channels. J Neurosci. 2000 May 15; 20(10):3563-70.
Score: 0.008